ODDB.org: Open Drug Database

Home - 57047 - 01 - 003

Co-Amoxi-Mepha 457, Pulver zur Herstellung einer Suspension zum Einnehmen - 70 ml

Swissmedic Key	57047003	Registration Holder	Mepha Pharma AG
Name	Co-Amoxi-Mepha 457, Pulver zur Herstellung einer Suspension zum Einnehmen	Date of registration	11.05.2005
Original/Generic	Generic	Introduction of Sequence	11.05.2005
ATC-Classification	Amoxicillin and Beta-Lactamase Inhibitor (J01CR02)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.01.93.	Show package size	70 ml
Index Therapeuticus (Swissmedic)	08.01.93.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	8.01	Limitation	No

Deductible	10 %	Consumer price	17.40
Feedback	FB
GTIN	7680570470033	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

amoxicillinum anhydricum 400 mg ut amoxicillinum trihydricum, acidum clavulanicum 57 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aspartamum 16.64 mg, aromatica (Erdbeer) cum alcohol benzylicus et propylenglycolum, ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium max. 7.3 mg.

Packungsbestandteile

Galenic Form

Pulver zur Herstellung einer Suspension zum Einnehmen

Excipiens

Active Agent	Dose
Clavulanic Acid	57 mg
Amoxicillin Anhydride	400 mg

BAG: Active Agent	Dose
Clavulanic Acid	57 mg
Amoxicillin Anhydride	400 mg

Inactive agents	Dose
Aromatica (Erdbeer) cum Alcohol Benzylicus
Aspartame	16.64 mg
Carmellose Sodium
Crospovidonum
Propylenglycol
Silica Colloidalis Anhydrica
Xanthani Gummi

Source

Data was imported : 06.07.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH